Active Biotech AB : 600 Patients Recruited in Active Biotech’s and Ipsen’s tasquinimod Clinical Phase III Study – 4-traders (press release)
Active Biotech AB (NASDAQ OMX NORDIC ... unless so required by applicable law. The Group's business is subject to the risk factors outlined in its registration documents filed with the French Autorité des Marchés Financiers. E-mail ...
Subscribe to LegalLaw247.Com Newsletter
